All Stories

  1. Managing the Co-Creation Process
  2. Developing Indicators of Open Innovation Event Outcomes
  3. Patterns of Information-Seeking of Patients Newly Diagnosed with Inflammatory Bowel Disease
  4. The Medical Care Process of Inflammatory Bowel Diseases in Canada
  5. Success of Open Innovation Events for Solvers
  6. THE LIMITS TO INTERNATIONAL OPEN INNOVATION WITHIN SMEs: THE ROLE OF DISTANCE
  7. Using local OI to access relevant external knowledge through spatial proximity
  8. Board and innovation: A systematic review of the literature from a contingency perspective.
  9. Les pratiques de communication marketing à l’entrée et à la post-entrée internationale
  10. Understanding the specific characteristics and determinants of open innovation
  11. Organizational Culture Change and Employee Mobilization
  12. Local Open Innovation: A means for public policy to increase collaboration for innovation in SMEs
  13. Knowledge and understanding of pharmacogenomic testing among patients and health care professionals: A scoping review
  14. Patient and Health Care Provider Needs and Preferences in Understanding Pharmacogenomic and Genomic Testing: A Meta-Data Analysis
  15. Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures
  16. Québec SME Risk Management and Exports to Asian Countries
  17. Patients' perception of their involvement in shared treatment decision making
  18. Quand le capital de risque influence la motivation des entrepreneurs
  19. Opportunity recognition by international high-technology start-up and growth photonics firms
  20. Opportunity recognition by international high-technology start-up and growth photonics firms
  21. Profitable Growth Through International High-Technology Product and Market Development
  22. Profitable growth through international high-technology product and market development
  23. Local Open Innovation: How Spatial Closeness Facilitates Profiting from Distant Search
  24. Exploring the Use of a Participative Design in the Early Development of a Predictive Test
  25. FACTORS LEADING TO ACCEPTANCE OF, AND WILLINGNESS TO PAY FOR PREDICTIVE TESTING AMONG CHRONICALLY ILL PATIENTS
  26. Functional and contextual dimensions of INVs’ alliance partner selection
  27. A conceptual framework on the role of creativity in sustaining continuous innovation in new product development
  28. ACCELERATING THE PACE OF INNOVATION THROUGH UNIVERSITY-INDUSTRY COLLABORATION ENHANCEMENT: IN SEARCH OF MUTUAL BENEFITS AND TRUST BUILDING
  29. Strategic use of corporate and scientific boards in the internationalisation of biotech firms
  30. International strategic alliances of small biotechnology firms: a second-best option?
  31. SMEs internationalization through alliances
  32. Influence of entry modes on communication strategies of international new ventures in foreign markets: a preliminary study
  33. Influence of Star Bioscientists on Obtaining Venture Capital for Canadian Dedicated Biotechnology Firms
  34. Influence of Star Bioscientists on Obtaining Venture Capital for Canadian Dedicated Biotechnology Firms